|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
gptkb:Craig_Thompson
|
|
gptkbp:collaboratesWith
|
gptkb:Merck_&_Co.
gptkb:Takeda_Pharmaceutical_Company
|
|
gptkbp:focus
|
neuroscience
central nervous system diseases
|
|
gptkbp:founded
|
2016
|
|
gptkbp:founder
|
gptkb:Brad_Margus
gptkb:Nathaniel_Heintz
|
|
gptkbp:hasResearchCenter
|
gptkb:Cambridge,_UK
gptkb:Cambridge,_MA,_USA
|
|
gptkbp:headquarters
|
gptkb:Cambridge,_Massachusetts,_United_States
gptkb:Cambridge,_United_Kingdom
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:investor
|
gptkb:Bill_Gates
gptkb:Google_Ventures
gptkb:Takeda_Ventures
|
|
gptkbp:numberOfEmployees
|
approximately 50 (as of 2023)
|
|
gptkbp:products
|
gptkb:CVN293
gptkb:CVN424
gptkb:CVN766
|
|
gptkbp:technology
|
gptkb:NETSseq
|
|
gptkbp:therapeuticArea
|
gptkb:Alzheimer's_disease
gptkb:Amyotrophic_lateral_sclerosis
gptkb:Parkinson's_disease
|
|
gptkbp:website
|
https://www.cerevance.com/
|
|
gptkbp:bfsParent
|
gptkb:Mark_Leschly
gptkb:Osage_University_Partners
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Cerevance
|